Talk
mTOR Signaling in Growth and Metabolism: How an Unhealthy Diet Causes Diabetes
Monday, February 17, 2020, 6:30PM
NYUAD Campus, Conference Center
Past Event
Open to the Public
TOR (Target of Rapamycin) is a highly conserved protein kinase that controls a wide range of metabolic processes. More importantly, TOR is a central controller of cell growth that plays a key role in development and ageing. Dysregulated mTOR (mammalian TOR) is implicated in many disorders including cancer, cardiovascular disease, and diabetes. The aim of this group's research is to elucidate the mechanisms by which mTOR signaling is regulated and how it, in turn, controls many processes in both health and disease.
TOR (Target of Rapamycin) is a highly conserved protein kinase that controls a wide range of metabolic processes. More importantly, TOR is a central controller of cell growth that plays a key role in development and ageing. Dysregulated mTOR (mammalian TOR) is implicated in many disorders including cancer, cardiovascular disease, and diabetes. The aim of this group's research is to elucidate the mechanisms by which mTOR signaling is regulated and how it, in turn, controls many processes in both health and disease.
- Michael N. Hall, Professor of Biochemistry and Head of Research Group, University of Basel